Concepedia

Shivaani Kummar

SK

139

Publications

11.4K

Citations

46

H-Index

2001

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

The University of Texas MD Anderson Cancer Center

Stanford University

Frederick National Laboratory for Cancer Research

Shivaani Kummar is an author at National Cancer Institute specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2001–2025

139

Publications

139

Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children

Alexander Drilon, Theodore W. Laetsch, Shivaani Kummar et al. · New England Journal of Medicine · 2018 · 2.6K citations · Full text

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

David S. Hong, Steven G. DuBois, Shivaani Kummar et al. · The Lancet Oncology · 2020 · 955 citations · Full text

, , +9

SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

Antoni Ribas, Theresa Medina, Shivaani Kummar et al. · Cancer Discovery · 2018 · 328 citations · Full text

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

Shivaani Kummar, Robert J. Kinders, Martin Gutierrez et al. · Journal of Clinical Oncology · 2009 · 324 citations · Full text

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Lawrence Fong, Andrew Hotson, John D. Powderly et al. · Cancer Discovery · 2019 · 321 citations · Full text

Rows per page

1–5 of 139